BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18430491)

  • 1. BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection.
    Orlando F; Ghiselli R; Cirioni O; Minardi D; Tomasinsig L; Mocchegiani F; Silvestri C; Skerlavaj B; Riva A; Muzzonigro G; Saba V; Scalise G; Zanetti M; Giacometti A
    Peptides; 2008 Jul; 29(7):1118-23. PubMed ID: 18430491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of tigecycline and rifampin alone and in combination against Enterococcus faecalis biofilm infection in a rat model of ureteral stent.
    Minardi D; Cirioni O; Ghiselli R; Silvestri C; Mocchegiani F; Gabrielli E; d'Anzeo G; Conti A; Orlando F; Rimini M; Brescini L; Guerrieri M; Giacometti A; Muzzonigro G
    J Surg Res; 2012 Jul; 176(1):1-6. PubMed ID: 21704328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
    Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
    Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.
    Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Silvestri C; Orlando F; Mocchegiani F; Vittoria AD; Kamysz E; Saba V; Scalise G
    Peptides; 2007 Jun; 28(6):1299-303. PubMed ID: 17537542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Gov Y; Kamysz W; Lukasiak J; Mocchegiani F; Orlando F; D'Amato G; Balaban N; Saba V; Scalise G
    Circulation; 2003 Aug; 108(6):767-71. PubMed ID: 12885754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
    J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
    Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
    J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
    Monzón M; García-Alvarez F; Laclériga A; Gracia E; Leiva J; Oteiza C; Amorena B
    J Orthop Res; 2001 Sep; 19(5):820-6. PubMed ID: 11562127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms.
    Gracia E; Laclériga A; Monzón M; Leiva J; Oteiza C; Amorena B
    J Surg Res; 1998 Oct; 79(2):146-53. PubMed ID: 9758730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary investigations on a new gentamicin and vancomycin-coated PMMA nail for the treatment of bone and intramedullary infections: An experimental study in the rabbit.
    Giavaresi G; Borsari V; Fini M; Giardino R; Sambri V; Gaibani P; Soffiatti R
    J Orthop Res; 2008 Jun; 26(6):785-92. PubMed ID: 18186130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
    Keeling WB; Myers AR; Stone PA; Heller L; Widen R; Back MR; Johnson BL; Bandyk DF; Shames ML
    J Surg Res; 2009 Dec; 157(2):223-6. PubMed ID: 19560786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection.
    Cirioni O; Ghiselli R; Minardi D; Orlando F; Mocchegiani F; Silvestri C; Muzzonigro G; Saba V; Scalise G; Balaban N; Giacometti A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4518-20. PubMed ID: 17875996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
    Cirioni O; Ghiselli R; Silvestri C; Minardi D; Gabrielli E; Orlando F; Rimini M; Brescini L; Muzzonigro G; Guerrieri M; Giacometti A
    J Antimicrob Chemother; 2011 Jun; 66(6):1318-23. PubMed ID: 21406436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
    Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G
    Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats.
    Kalteis T; Beckmann J; Schröder HJ; Handel M; Grifka J; Lehn N; Lerch K
    Acta Orthop; 2006 Apr; 77(2):315-9. PubMed ID: 16752296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides.
    Cirioni O; Silvestri C; Ghiselli R; Giacometti A; Orlando F; Mocchegiani F; Chiodi L; Vittoria AD; Saba V; Scalise G
    Peptides; 2006 Nov; 27(11):2600-6. PubMed ID: 16797106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model.
    Barnea Y; Carmeli Y; Kuzmenko B; Navon-Venezia S
    J Antimicrob Chemother; 2008 Dec; 62(6):1339-43. PubMed ID: 18799473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of implant-associated infections with moxifloxacin: an animal study.
    Kalteis T; Beckmann J; Schröder HJ; Schaumburger J; Linde HJ; Lerch K; Lehn N
    Int J Antimicrob Agents; 2006 May; 27(5):444-8. PubMed ID: 16621461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.